Dyadic International, Inc. (DYAI)Healthcare | Biotechnology | Jupiter, United States | NasdaqCM
0.61 USD
-0.03
(-3.912%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.64 +0.03 (4.218%) ⇧ (Aug. 28, 2026, 5:11 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:37 a.m. EDT
Dyadic International presents a severe fundamental deterioration that overrides any analyst optimism. The company is trapped in a multi-year structural decline, having lost nearly 41% of its value over the last nine years with five consecutive years of negative annual returns. Despite a 'strong buy' recommendation and a lofty analyst target price, the underlying reality is stark: the business is generating negative free cash flow, burning through capital, and trading at a negative book value. The recent price action confirms this gravity, with the stock tumbling from $1.08 to $0.69 in just two weeks, erasing recent gains. With no dividend to provide income and a balance sheet showing debt exceeding cash, the 'value' here is an illusion created by a disconnect between analyst models and the deteriorating operational reality. This is a classic value trap where the market has correctly priced out the business quality. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.282343 |
| AutoETS | 0.287113 |
| AutoTheta | 0.294545 |
| MSTL | 0.295398 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 0.19 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.325 |
| Excess Kurtosis | -0.75 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.106 |
| Market Cap | 24,603,120 |
| Forward P/E | -1.92 |
| Beta | 1.02 |
| Profit Margins | -200.46% |
| Website | https://www.dyadic.com |
As of Aug. 22, 2026, 5:37 a.m. EDT: Options activity is virtually dormant with negligible open interest and volume across all expirations. Implied volatility is extremely low, indicating a lack of speculative positioning or hedging demand. The absence of put buying suggests no immediate fear of a crash, while the lack of call buying confirms no bullish bets are being placed on a recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.32631576 |
| Address1 | 1,044 North U.S. Highway One |
| Address2 | Suite 201 |
| All Time High | 10.98 |
| All Time Low | 0.05 |
| Ask | 0.793 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 130,970 |
| Average Daily Volume3 Month | 212,583 |
| Average Volume | 212,583 |
| Average Volume10Days | 130,970 |
| Beta | 1.024 |
| Bid | 0.4473 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | -0.066 |
| City | Jupiter |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.6141 |
| Current Ratio | 1.65 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.65 |
| Day Low | 0.6002 |
| Display Name | Dyadic |
| Earnings Call Timestamp End | 1,786,568,400 |
| Earnings Call Timestamp Start | 1,786,568,400 |
| Earnings Timestamp | 1,786,537,800 |
| Earnings Timestamp End | 1,794,400,200 |
| Earnings Timestamp Start | 1,794,400,200 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 6.393 |
| Enterprise Value | 24,309,352 |
| Eps Forward | -0.32 |
| Eps Trailing Twelve Months | -0.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 561 743 8343 |
| Fifty Day Average | 0.9598 |
| Fifty Day Average Change | -0.34570003 |
| Fifty Day Average Change Percent | -0.36017922 |
| Fifty Two Week Change Percent | -32.631577 |
| Fifty Two Week High | 1.6 |
| Fifty Two Week High Change | -0.98590004 |
| Fifty Two Week High Change Percent | -0.6161875 |
| Fifty Two Week Low | 0.6 |
| Fifty Two Week Low Change | 0.014099956 |
| Fifty Two Week Low Change Percent | 0.023499925 |
| Fifty Two Week Range | 0.6 - 1.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,200,493,800,000 |
| Float Shares | 27,495,552 |
| Forward Eps | -0.32 |
| Forward P E | -1.9190625 |
| Free Cashflow | -4,809,161 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Fullday Change | -0.025 |
| Fullday Change Percent | -3.91176 |
| Fullday Price | 0.64 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.16244 |
| Gross Profits | 617,621 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.22896999 |
| Held Percent Institutions | 0.12324 |
| Implied Shares Outstanding | 40,063,703 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. |
| Long Name | Dyadic International, Inc. |
| Market | us_market |
| Market Cap | 24,603,120 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_4272801 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -7,621,842 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 25,468,495 |
| Number Of Analyst Opinions | 2 |
| Open | 0.65 |
| Operating Cashflow | -7,403,841 |
| Operating Margins | -2.12822 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 561 743 8333 |
| Post Market Change | 0.025900006 |
| Post Market Change Percent | 4.2175555 |
| Post Market Price | 0.64 |
| Post Market Time | 1,787,951,488 |
| Previous Close | 0.6391 |
| Price Hint | 4 |
| Price To Book | -9.304545 |
| Price To Sales Trailing12 Months | 6.470696 |
| Profit Margins | -2.00457 |
| Quick Ratio | 1.141 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.025 |
| Regular Market Change Percent | -3.91176 |
| Regular Market Day High | 0.65 |
| Regular Market Day Low | 0.6 |
| Regular Market Day Range | 0.6 - 0.65 |
| Regular Market Open | 0.65 |
| Regular Market Previous Close | 0.6391 |
| Regular Market Price | 0.6141 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 276,547 |
| Return On Assets | -0.62994 |
| Revenue Growth | -0.006 |
| Revenue Per Share | 0.106 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 40,063,703 |
| Shares Percent Shares Out | 0.0041 |
| Shares Short | 164,738 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 83,534 |
| Short Name | Dyadic International, Inc. |
| Short Percent Of Float | 0.0047999998 |
| Short Ratio | 0.7 |
| Source Interval | 15 |
| State | FL |
| Symbol | DYAI |
| Target High Price | 7.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 5.5 |
| Target Median Price | 5.5 |
| Total Cash | 3,113,719 |
| Total Cash Per Share | 0.085 |
| Total Debt | 5,046,064 |
| Total Revenue | 3,802,237 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.2 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.87245 |
| Two Hundred Day Average Change | -0.25835 |
| Two Hundred Day Average Change Percent | -0.29612014 |
| Type Disp | Equity |
| Volume | 276,547 |
| Website | https://www.dyadic.com |
| Zip | 33,477-5094 |